Patents by Inventor Jack U'ren

Jack U'ren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070099184
    Abstract: This invention provides for a novel amplification procedure for nucleic acid. The method uses a wild type or mutant RNA polymerase designed to transcribe both deoxyribonucleotides and ribonucleotides (see FIGS. 1-7).
    Type: Application
    Filed: June 7, 2002
    Publication date: May 3, 2007
    Inventors: Paul Haydock, Jack U'ren
  • Patent number: 7074558
    Abstract: This invention provides for a novel amplification procedure for nucleic acid. The method uses a wild type or mutant RNA polymerase designed to transcribe both deoxyribonucleotides and ribonucleotides.
    Type: Grant
    Filed: February 15, 2002
    Date of Patent: July 11, 2006
    Assignee: PBI Technology, Inc.
    Inventors: Paul V. Haydock, Jack U'ren
  • Publication number: 20030050444
    Abstract: This invention provides for a novel amplification procedure for nucleic acid. The method uses a wild type or mutant RNA polymerase designed to transcribe both deoxyribonucleotides and ribonucleotides.
    Type: Application
    Filed: February 15, 2002
    Publication date: March 13, 2003
    Applicant: Saigene Corporation
    Inventors: Paul V. Haydock, Jack U'ren
  • Patent number: 6319671
    Abstract: Methods for detecting in a human biological sample the presence of HLA DQB1 alleles 0201/0202, 0302/0303, and/or 0602 which are associated with increased or decreased susceptibility to insulin dependent diabetes mellitus.
    Type: Grant
    Filed: December 13, 2000
    Date of Patent: November 20, 2001
    Assignee: Saigene Corporation
    Inventors: Jack U'ren, Sharon Howard, Vivian H. Gersuk
  • Patent number: 6280945
    Abstract: A method of determining the presence of a nucleic acid analyte from a sample comprising binding a biotinylated capture oligonucleotide to a solid phase non-covalently coated with streptavidin or an avidin derivative. The capture oligonucleotide is contacted with and selectively hybridized to, under stringent hybridization conditions, a nucleic acid analyte to form a detectable hybridization complex.
    Type: Grant
    Filed: January 6, 2000
    Date of Patent: August 28, 2001
    Assignee: Saigene Corporation
    Inventor: Jack U'ren
  • Patent number: 5785925
    Abstract: A centrifuge sample tube phase separation plug is disclosed for use in conjunction with sample tube to effect organic solvent separation on a volumetric basis. The centrifuge sample tube is of the type having a conical bottom end closed at the apex with an upward extending cylindrical portion opening to the top of the sample tube. A centrifuge sample tube cap is provided to close the sample tube with the mixed organic solvent and sample. The sample tube cap contains a plug having a central aperture and a tapered profile for fitting into the top of the conical bottom section of the centrifuge sample tube. Presuming that the sample tube is loaded and capped with mixed organic solvent and sample, centrifugation occurs. Into the centrifugation process, the plug releases from the cap and passes from the cap area, through the sample, to the top of the conical portion of the centrifuge sample tube.
    Type: Grant
    Filed: August 29, 1996
    Date of Patent: July 28, 1998
    Assignee: Saigene Corporation
    Inventor: Jack U'Ren